Gylvin Lykke Hinsch
Director · ProQR Therapeutics N.V.
Individual
- 2026
- Jun 30, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Gylvin Lykke Hinsch files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Boer Daniel Anton de - $853K in PRQR purchases and sales in the last 12 months
- Bart Filius - $489K in PRQR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Gylvin Lykke Hinsch?
Gylvin Lykke Hinsch is a corporate insider, tracked as Director of ProQR Therapeutics N.V. (PRQR). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Gylvin Lykke Hinsch last file a Form 4?
The most recent primary Form 4 on record is dated 30 June 2026, one of 2 filings going back to 2026.